Nevertheless, our data can be used to design small molecule inhibitors for other pharmaceutical targets, for example ADAMTS4 and ADAMTS5 in osteoarthritis (88), ADAMTS7 in atherosclerosis (89), or ADAMTS8 in pulmonary arterial hypertension (90), which spare ADAMTS9. Here, ADAMTS5 is linked to osteoarthritis.